Literature DB >> 5014310

Relationship between dose and plateau levels of drugs eliminated by parallel first-order and capacity-limited kinetics.

T Tsuchiya, G Levy.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 5014310     DOI： 10.1002/jps.2600610409

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  20 in total

1.  Area-dose relationships in nonlinear models.

Authors:  N P Chau
Journal:  J Pharmacokinet Biopharm       Date:  1976-12

2.  Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys.

Authors:  Patrick M Glassman; Yang Chen; Joseph P Balthasar
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-12       Impact factor: 2.745

3.  Nonlinear assessment of phenytoin bioavailability.

Authors:  W J Jusko; J R Koup; G Alván
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

4.  Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol.

Authors:  G Alván; M Lind; B Mellström; C von Bahr
Journal:  J Pharmacokinet Biopharm       Date:  1977-06

Review 5.  A modern view of pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1973-10

6.  Bioavailability limits.

Authors:  G Levy
Journal:  Can Med Assoc J       Date:  1972-10-21       Impact factor: 8.262

7.  Nonlinear kinetics of nortriptyline in relation to nortriptyline clearance as observed during therapeutic drug monitoring.

Authors:  M Jerling; G Alván
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

8.  The pharmacokinetics of neostigmine and 3-hydroxyphenyltrimethyl- ammonium in the rat: dose-dependent effects after portal vein administration.

Authors:  H E Barber; G R Bourne
Journal:  Br J Pharmacol       Date:  1974-12       Impact factor: 8.739

9.  Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.

Authors:  J Shen; S Wanwimolruk; R D Purves; E G McQueen; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

10.  Monitoring plasma concentrations of salicylate.

Authors:  M Mandelli; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.